SRSF2 (also referred to as SC35) was demonstrated to interfere with the tumor-suppressive signature of the KLF6 gene by inducing the generation of exon 1a-included transcripts, consequently encoding the DNA-binding domain-deficient isoform [31]. Here, SRSF2 is linked to neoplasm.